These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 27404371
1. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency. Nisii C, Vincenti D, Fusco FM, Schmidt-Chanasit J, Carbonnelle C, Raoul H, Eickmann M, Hewson R, Brave A, Nuncio S, Sanchez-Seco MP, Palyi B, Kis Z, Zange S, Nitsche A, Kurth A, Strasser M, Capobianchi MR, Ozin A, Guglielmetti P, Menel-Lemos C, Jacob D, Grunow R, Ippolito G, Di Caro A. Clin Microbiol Infect; 2017 Feb; 23(2):58-60. PubMed ID: 27404371 [No Abstract] [Full Text] [Related]
2. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet. Reusken CB, Mögling R, Smit PW, Grunow R, Ippolito G, Di Caro A, Koopmans M. Euro Surveill; 2018 May; 23(19):. PubMed ID: 29766839 [Abstract] [Full Text] [Related]
3. Validating the Inactivation Effectiveness of Chemicals on Ebola Virus. Haddock E, Feldmann F. Methods Mol Biol; 2017 May; 1628():251-257. PubMed ID: 28573626 [Abstract] [Full Text] [Related]
4. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic. Zhang Y, Gong Y, Wang C, Liu W, Wang Z, Xia Z, Bu Z, Lu H, Sun Y, Zhang X, Cao Y, Yang F, Su H, Hu Y, Deng Y, Zhou B, Zhao Z, Fu Y, Kargbo D, Dafae F, Kargbo B, Kanu A, Liu L, Qian J, Guo Z. PLoS Negl Trop Dis; 2017 May; 11(5):e0005622. PubMed ID: 28505171 [Abstract] [Full Text] [Related]
6. European perspective of 2-person rule for biosafety level 4 laboratories. Ippolito G, Nisii C, Di Caro A, Brown D, Gopal R, Hewson R, Lloyd G, Gunther S, Eickmann M, Mirazimi A, Koivula T, Georges Courbot MC, Raoul H, Capobianchi MR. Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889 [No Abstract] [Full Text] [Related]
7. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017. Appelt S, Jacob D, Rohleder AM, Bråve A, Szekely Björndal Å, Di Caro A, Grunow R, Joint Action EMERGE laboratory networkThe EMERGE partners are acknowledged at the end of the article.. Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748 [Abstract] [Full Text] [Related]
8. Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come. Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ. J Infect Dis; 2016 Oct 15; 214(suppl 3):S137-S141. PubMed ID: 27651413 [Abstract] [Full Text] [Related]
9. Why Japan imported Ebola ahead of the 2020 Olympics. Zastrow M. Nature; 2019 Oct 15; 574(7778):306-307. PubMed ID: 31616102 [No Abstract] [Full Text] [Related]
10. Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory. Pentella MA. Clin Lab Med; 2020 Dec 15; 40(4):473-482. PubMed ID: 33121616 [Abstract] [Full Text] [Related]
11. Gleanings from the harvest: suggestions for priority actions against Ebola virus epidemics. Johnson KM. J Infect Dis; 1999 Feb 15; 179 Suppl 1():S287-8. PubMed ID: 9988198 [No Abstract] [Full Text] [Related]
12. Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients. Tempestilli M, Pucci L, Notari S, Di Caro A, Castilletti C, Rivelli MR, Agrati C, Pucillo LP. Clin Chem Lab Med; 2015 Nov 15; 53(12):1967-73. PubMed ID: 26053010 [Abstract] [Full Text] [Related]
13. Pseudoparticle neutralization assay for detecting ebola- neutralizing antibodies in biosafety level 2 settings. Chin AW, Perera RA, Guan Y, Halfmann P, Kawaoka Y, Peiris M, Poon LL. Clin Chem; 2015 Jun 15; 61(6):885-6. PubMed ID: 25829407 [No Abstract] [Full Text] [Related]
14. Ebola virus disease: Biological and diagnostic evolution from 2014 to 2017. Mérens A, Bigaillon C, Delaune D. Med Mal Infect; 2018 Mar 15; 48(2):83-94. PubMed ID: 29224715 [Abstract] [Full Text] [Related]
15. [Mobile laboratories for rapid deployment and their contribution to the containment of emerging diseases in Sub-Saharan Africa, illustrated by the example of Ebola virus disease]. Diers J, Kouriba B, Ladan Fofana L, Fleischmann E, Starke M, Diallo S, Babin FX, von Bonin J, Wölfel R. Med Sante Trop; 2015 Mar 15; 25(3):229-33. PubMed ID: 26446739 [Abstract] [Full Text] [Related]
16. Ebola Virus Disease: Clinical Challenges, Recognition, and Management. Beam EL, Schwedhelm MM, Boulter KC, Vasa AM, Larson L, Cieslak TJ, Lowe JJ, Herstein JJ, Kratochvil CJ, Hewlett AL. Nurs Clin North Am; 2019 Jun 15; 54(2):169-180. PubMed ID: 31027659 [Abstract] [Full Text] [Related]
17. Development and use of mobile containment units for the evaluation and treatment of potential Ebola virus disease patients in a United States hospital. Sugalski G, Murano T, Fox A, Rosania A. Acad Emerg Med; 2015 May 15; 22(5):616-22. PubMed ID: 25900204 [Abstract] [Full Text] [Related]
18. ["Ebola: a major humanitarian crisis that may linger" (Pr Peter Piot)]. Piot P, Nau JY. Rev Med Suisse; 2014 Oct 08; 10(445):1892-3. PubMed ID: 25417363 [No Abstract] [Full Text] [Related]
19. Building Biosafety Capacity in Our Nation's Laboratories. Chung CL, Bellis KS, Pullman A, O'Connor A, Shultz A. Health Secur; 2019 Oct 08; 17(5):353-363. PubMed ID: 31593513 [Abstract] [Full Text] [Related]
20. Smart Card Decontamination in a High-Containment Laboratory. Gabbert LR, Smith JD, Neilan JG, Ferman GS, Rasmussen MV. Health Secur; 2018 Oct 08; 16(4):244-251. PubMed ID: 30096256 [Abstract] [Full Text] [Related] Page: [Next] [New Search]